Archive - April 2021
Enhertu accepted via cancer drugs fund for HER2-positive breast cancer
NICE’s five-year strategy sets a ‘positive vision for the future’
UK-based challenge study to re-expose healthy adults to COVID-19
Italy accelerates the path towards digital therapeutics implementation
Roche’s Ocrevus shows significant benefit in early-stage MS patients
Second Sarclisa combination regimen for multiple myeloma approved in EU
NICE unveils new strategy to improve patient access to innovative treatments
Moderna COVID-19 vaccine shortfall could affect UK supply